Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis
29 juil. 2020 13h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
23 juin 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
12 juin 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 12, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Presentation at BIO Digital 2020
08 juin 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 08, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
14 mai 2020 16h05 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 14, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
11 mai 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020
07 mai 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Altair Accelerates Simulation-Driven Design in Latest Release of Altair Inspire™
21 avr. 2020 07h00 HE
|
Altair Engineering Inc.
TROY, Mich., April 21, 2020 (GLOBE NEWSWIRE) -- Altair, (Nasdaq: ALTR) a global technology company providing solutions in product development, high-performance computing (HPC), and data analytics,...
Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial Results
24 mars 2020 16h05 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results
18 mars 2020 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...